Clinical trial

Fingolimod for Type 2 Diabetes Mellitus

NCT05307731

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-03-15

PhasePHASE4

Study timeline

Study start (actual)2022-03-15Date precision: day

Registry last updated2026-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

FingolimodDRUG · verified · RxNorm: fingolimod

guideline-based treatment for DMDRUG

Sponsors & collaborators

General Hospital of Shenyang Military Regionlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05307731 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.